Business Description
Fresh Tracks Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US9256022032
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 572 | |||||
Equity-to-Asset | 0.86 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -18.74 | |||||
Beneish M-Score | -4.26 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.7 | |||||
3-Year EBITDA Growth Rate | 69.9 | |||||
3-Year EPS without NRI Growth Rate | 69.8 | |||||
3-Year FCF Growth Rate | 72 | |||||
3-Year Book Growth Rate | -58.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.51 | |||||
9-Day RSI | 41.54 | |||||
14-Day RSI | 43.16 | |||||
6-1 Month Momentum % | 3.56 | |||||
12-1 Month Momentum % | -40.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.98 | |||||
Quick Ratio | 6.98 | |||||
Cash Ratio | 6.56 | |||||
Days Sales Outstanding | 5.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -71.2 | |||||
Shareholder Yield % | -120.55 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -79.44 | |||||
Net Margin % | -71.12 | |||||
FCF Margin % | -57.34 | |||||
ROE % | -61.98 | |||||
ROA % | -50.19 | |||||
ROIC % | -606.52 | |||||
ROC (Joel Greenblatt) % | -7814.56 | |||||
ROCE % | -61.93 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.67 | |||||
PB Ratio | 0.55 | |||||
Price-to-Tangible-Book | 0.53 | |||||
EV-to-EBIT | 0.61 | |||||
EV-to-Forward-EBIT | 0.01 | |||||
EV-to-EBITDA | 0.62 | |||||
EV-to-Revenue | -0.44 | |||||
EV-to-Forward-Revenue | 173.26 | |||||
EV-to-FCF | 0.8 | |||||
Price-to-Median-PS-Value | 0.23 | |||||
Price-to-Net-Current-Asset-Value | 0.53 | |||||
Price-to-Net-Cash | 0.59 | |||||
Earnings Yield (Greenblatt) % | 163.93 | |||||
FCF Yield % | -79.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fresh Tracks Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 9.436 | ||
EPS (TTM) (€) | -2.541 | ||
Beta | 0 | ||
Volatility % | 112.24 | ||
14-Day RSI | 43.16 | ||
14-Day ATR (€) | 0.023197 | ||
20-Day SMA (€) | 0.74925 | ||
12-1 Month Momentum % | -40.6 | ||
52-Week Range (€) | 0.4404 - 3.4 | ||
Shares Outstanding (Mil) | 5.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fresh Tracks Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fresh Tracks Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fresh Tracks Therapeutics Inc Frequently Asked Questions
What is Fresh Tracks Therapeutics Inc(FRA:VCC)'s stock price today?
When is next earnings date of Fresh Tracks Therapeutics Inc(FRA:VCC)?
Does Fresh Tracks Therapeutics Inc(FRA:VCC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |